Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR

  • Yoon Ji Choi
  • , Dae Ho Lee
  • , Chang Min Choi
  • , Jung Shin Lee
  • , Seung Jin Lee
  • , Jin Hee Ahn
  • , Sang We Kim*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

18   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science